By Mill Chart
Last update: Jun 7, 2025
ADMA BIOLOGICS INC (NASDAQ:ADMA) stands out as a high-growth momentum candidate with a solid technical setup, according to our screening criteria. The company, which specializes in plasma-derived biologics, has demonstrated strong earnings and revenue growth while maintaining a favorable technical structure for potential breakout opportunities.
For a deeper technical breakdown, review the full technical report for ADMA.
Our High Growth Momentum Breakout Setups Screen lists more stocks with similar characteristics and is updated daily.
This is not investment advice. The observations here are based on current data, but market conditions can change. Always conduct your own research before making investment decisions.
20.61
+0.67 (+3.36%)
Find more stocks in the Stock Screener
ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout opportunity.
ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech sector.